Itonis Inc (ITNS) 0.0208 $ITNS Itonis, Inc. OTCpink ITNS

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Itonis Inc (ITNS) 0.0208 $ITNS

Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.

Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.

Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:

Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX

Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.

Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.

Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.

Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.

Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
Marketwire - Wed Dec 04, 9:58AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has completed packaging graphics for its Emesyl(TM) Nausea Remedy.

Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy
Marketwire - Mon Dec 02, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company will conduct a case study to confirm the efficacy of its Emesyl(TM) Nausea Remedy in a clinical setting.

Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 25, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are to receive first batch of Emesyl(TM) product, the Company's over-the-counter homeopathic product for the relief of nausea.

Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 18, 8:50AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to release their manufacturing update for Emesyl(TM), the Company's over-the-counter homeopathic product for the relief of nausea.

Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy
Marketwire - Thu Oct 24, 9:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has applied to the USPTO to trademark its Emesyl brand for its homeopathic pharmaceutical nausea relief remedy. The Company's application has been assigned Serial No. 86099093.

Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD") will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.

Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains
Marketwire - Fri Jul 19, 8:45AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status
Marketwire - Tue Jun 25, 1:30PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.

Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013
GlobeNewswire - Fri May 31, 8:30AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.

Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 11:53AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.

Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 10:00AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 62

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
AI Forces Learning Teams to Redefine Their Core Job

Updated Category News Views 133

Training Departments Are Not Sitting Still Corporate learning has spent years being treated like the office instruction manual, and AI is making that old arrangement look awfully flimsy. RedThread Research's November 19, 2026 study lands on a point that ought to make senior management pay attention: learning and development leaders are not merely waiting around to be...

Continue Reading
Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 86

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Thanksgiving Kitchen Safety Is No Place for Autopilot

Updated Category News Views 107

Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 20

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading
Tigo's Guidance Gap Draws Lawsuit and Investor Scrutiny

Updated Category News Views 18

A Revenue Promise Hit the Wall Solar investing can turn ugly in a hurry when a supposedly near-term catalyst gets shoved down the calendar. That is the central bruise behind the securities class action involving Tigo Energy, not some arcane accounting footnote that only lawyers can love. The complaint alleges Tigo overstated the revenue contribution it expected from its...

Continue Reading
SQM Investigation Puts Chile Approval Claims on Trial

Updated Category News Views 48

A Regulatory Promise Meets a Rough Earnings Reaction A 5.52% haircut after disappointing quarterly numbers is the sort of thing that makes shareholders stop pretending every loose management comment is harmless. Sociedad Química y Minera de Chile, NYSE:SQM, is facing an investigation by Levi & Korsinsky into public statements concerning regulatory matters, particularly...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 164

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
Software-Defined Cars Put $310 Billion in Play by 2035

Updated Category News Views 147

Cars are becoming rolling computers, and that changes who gets paid. Market Growth Reports projects the software-defined vehicle market will rise from $56.94 billion to $310.46 billion by 2035, a 20.74% compound annual growth rate. That is a loud number, no question. Still, investors ought to treat any long-range market forecast like a map, not a mortgage deed. The...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 59

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading

Top 5 Most Recently Viewed Articles

First Horizon Taps Kevin Piker to Boost Acadiana Ties

Updated Category News Views 22

Kevin Piker Joins First Horizon: A Strategic Move First Horizon Bank just made a move that's got tongues wagging in the banking world: they've roped in Kevin Piker as a Commercial Relationship Manager, specifically targeting the Acadiana market. Why's this a big deal, you ask? Well, this guy's got over 25 years in the trenches of banking and commercial lending, and he's...

Continue Reading
Tesla and Samsung's $2 Billion Energy Storage Partnership

Updated Category News Views 186

Tesla's Strategic Energy Storage Initiative Tesla Inc. (NASDAQ: TSLA) has taken a significant step forward by striking a $2 billion deal with Samsung SDI, a leading manufacturer in the energy storage technology sector. This agreement underscores Tesla's commitment to advancing its energy storage solutions, an area experiencing substantial growth in recent times. $2...

Continue Reading
Unlocking Business Growth: A New Mindset for Entrepreneurs

Updated Category News Views 267

Unlocking Business Growth: A New Mindset for Entrepreneurs As the years pass and entrepreneurs look for strategies to achieve success, business growth strategist and author Chad Smith warns against a damaging mindset. Many believe that waiting for the new year is the key to rejuvenating their business. However, Smith argues that this is a myth that can hinder progress....

Continue Reading
Exciting Merger Announcement: Cornerstone and Plumas Join Forces

Updated Category News Views 145

Strategic Merger Between Cornerstone and Plumas Bancorp Cornerstone Community Bancorp and Plumas Bancorp have recently made headlines with the shareholder approval for their merger. This significant step unites two reputable banking institutions, enhancing their capabilities and services offered to their customers. The merger will combine Cornerstone with Plumas,...

Continue Reading
Smart Investment Moves for Growing Companies in California

Updated Category Business Views 87

Smart Investment Moves for Growing Companies in California Growing a company in California can be exciting, but it can also become expensive very quickly. The state offers access to huge markets, strong tech networks, and a large pool of skilled workers. Many business owners see the Golden State as the perfect place to expand. Still, growth comes with pressure. Rent is...

Continue Reading